Auddia Lifts Bridge Funding Caps to $3.3M for Pending Thramann Merger Targets

summarizeSummary

Auddia amended its senior unsecured bridge notes to lend up to $3.3M to the Thramann merger targets, up from $1.4M, while the merger vote remains unresolved after the October 6 cancellation.

check_boxKey Events · M&A and Partnerships · AUUD

• Bridge Note Caps Raised to $3.3M

  An October 16, 2026 amendment lifts maximum funding to $420,000 for Thramann Holdings, $1,900,000 for LT350, $900,000 for Influence Healthcare and $85,000 for Voyex, versus $360,000, $400,000, $590,000 and $50,000 previously.

• LT350 Drives the Increase

  LT350's cap rises by $1.5M, from $400,000 to $1,900,000 — the bulk of the roughly $1.9M total increase in Auddia's commitment.

• Merger Vote Still Unresolved

  The October 7 special meeting was cancelled after 89% of votes cast favored the Thramann Holdings deal but failed to reach the Delaware majority-of-outstanding threshold.

• Funding Stops If Merger Terminated

  No further amounts will be funded if the pending Merger Agreement is terminated; advances over $50,000 require Audit Committee approval.

auto_awesomeAnalysis · AUUD · Technology

Auddia is committing more cash to the four companies it plans to merge with before shareholders have approved the deal. The bridge caps rise from $1.4M to $3.3M, with LT350 alone jumping from $400,000 to $1.9M. For a company that previously disclosed going-concern doubt and cash runway only into Q2 2027, that is real money, and it deepens Auddia's exposure to targets it does not yet own. The merger vote was cancelled on October 6 after 89% support fell short of Delaware's majority-of-outstanding threshold, so this funding keeps the targets alive while Auddia works out how to get the deal approved.